PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10971048-1	2000	Galantamine, a novel treatment for Alzheimer"s disease (AD), has a dual mechanism of action, combining allosteric modulation of nicotinic acetylcholine receptors with reversible, competitive inhibition of acetylcholinesterase.	Galantamine	0-11	acetylcholinesterase (Cartwright blood group)	Homo sapiens	205-225